| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2002;74:432-437
© 2002 The Society of Thoracic Surgeons
a Department of Cardiac Surgery and Research, The Prince Charles Hospital, Brisbane, Australia
Accepted for publication April 9, 2002.
* Address reprint requests to Dr O’Brien, Department of Cardiac Surgery, The Prince Charles Hospital, Rode Road, Chermside QLD 4032, Australia
e-mail: mark_obrien{at}health.qld.gov.au
Background. The recent emergence of BioGlue Surgical Adhesive has widened the field of surgical adhesives for the cardiac surgeon. We believe the present series, in a wider spectrum of cardiac conditions, is the first larger scale evaluation of the use of this new adhesive.
Methods. BioGlue was used in 115 consecutive patients (90 male and 25 female, age range 5 days to 87 years) from September 9, 1998 to March 12, 2001. Preoperative, intraoperative, and postoperative data were examined to establish its use, indications, and outcomes in patients undergoing cardiac surgical procedures.
Results. The most common underlying pathologic conditions were aortic dissections (30 patients) and aortic aneurysms (39 patients). The procedures carried out were aortic root replacement (36 patients), aortic wall replacement (39), ascending aorta repair (2), coronary artery bypass grafting (28), valve procedures (11), ventricular aneurysm repair (6), repair of postinfarct ventricular septal defect (2), and correction of congenital conditions (13 patients). The indications for BioGlue use were hemostasis in 79 patients, tissue adherence in 21, and tissue strengthening in 30. The hospital mortality was 10.1% (11 patients). Only 1 patient required a late reoperation for dehiscence of a suture line with formation of a false aneurysm. The mean postoperative blood loss at 12 hours was 702 mL. Ten patients developed a cerebrovascular accident postoperatively, which was considered to be unrelated to the use of BioGlue.
Conclusions. All surgeons in this study believed that BioGlue facilitated the operation. Future follow-up of patients is required to validate our early promising results and to assess the long-term outcome of patients treated with BioGlue.
This article has been cited by other articles:
|
|
 |
|
  M. Eto, S. Morita, M. Sugiura, T. Yoshimura, R. Tominaga, and T. Matsuda Elastomeric surgical sealant for hemostasis of cardiovascular anastomosis under full heparinization Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 730 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Zehr Use of Bovine Albumin-Glutaraldehyde Glue in Cardiovascular Surgery Ann. Thorac. Surg., September 1, 2007; 84(3): 1048 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Devbhandari, Q. Chaudhery, and A. J. Duncan Acute Intraoperative Malfunction of Aortic Valve Due to Surgical Glue Ann. Thorac. Surg., April 1, 2006; 81(4): 1499 - 1500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. LeMaire, S. A. Carter, T. Won, X. Wang, L. D. Conklin, and J. S. Coselli The Threat of Adhesive Embolization: BioGlue Leaks Through Needle Holes in Aortic Tissue and Prosthetic Grafts Ann. Thorac. Surg., July 1, 2005; 80(1): 106 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Economopoulos, G. K. Dimitrakakis, E. Brountzos, and D.A. Kelekis Superior vena cava stenosis: A delayed BioGlue complication J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1819 - 1821. [Full Text] [PDF]
|
|
|
|
|
|
D. Fink, J. J. Klein, H. Kang, and M. A. Ergin Application of biological glue in repair of intracardiac structural defects Ann. Thorac. Surg., February 1, 2004; 77(2): 506 - 511. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
